CWP
WST icon

Clark Wealth Partners’s West Pharmaceutical WST Stock Holding History

Clark Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44K Hold
4
– – ﹤0.01% 456
2026
Q1 		$1K Buy
+4
New +$995 ﹤0.01% 523
2025
Q3 		– Sell
-16
Closed -$3.5K – 649
2025
Q2 		$3.5K Buy
+16
New +$3.42K ﹤0.01% 323
2025
Q1 		– Sell
-10
Closed -$3.28K – 616
2024
Q4 		$3.28K Buy
+10
New +$3.15K ﹤0.01% 293

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clark Wealth Partners's WST Position: Q2 2026 in Review

Clark Wealth Partners held its West Pharmaceutical (WST) position steady in Q2 2026 at 4 shares worth $1.44K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

Clark Wealth Partners first reported a position in WST in Q4 2024 and has held it in 4 quarters since. The position peaked at $3.5K in Q2 2025. 785 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Clark Wealth Partners held 4 shares of West Pharmaceutical worth $1.44K as of Q2 2026.
  • Clark Wealth Partners left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Clark Wealth Partners's portfolio in Q2 2026, its #456 holding.
  • Clark Wealth Partners first reported a position in West Pharmaceutical in Q4 2024 and has held it in 4 quarters since.
  • Clark Wealth Partners's West Pharmaceutical position peaked at $3.5K in Q2 2025.
  • 785 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.